Prolate (Oxycodone HCl/Acetaminophen) Patent Expiration, LOE Window & CMS Spending

Prolate (Oxycodone HCl/Acetaminophen) by Forte Bio-: Off-Patent Genericized (AB Competition), 0 AB generics, $17.2M 2024 CMS Part D & Medicaid spend, and 3 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorForte Bio-
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$17.2M
2024 Medicare Part D Spend$7.4M
2024 Medicaid Spend$9.8M
Reported Wholesale Price Change (CA SB 17)3 WAC filings (max 9.2% 2-yr change)